1[1]Robert H, Hoffman M. Hemophilia and related conditionsinberited deficiencies of prothrombin (facter-Ⅱ ),factor Ⅴ and factor Ⅶ to Ⅻ [A].In:Beutler E.Williams Hematology[M]. 5th ed. New York: McGraw-Hill Inc, 1995.1413-1439.
4[5]Lacroix-Desmazes S, Misra N, Bayry J, et al. Pathophysiology of inhibitors to factor Ⅷ in patients with haemophilia A[J]. Haemophilia, 2002,8(3):273-279.
5[6]van Den Brink EN, Turehout EA, Davies J,et al. Human antibodies with specificity for the C2 domain of factor Ⅷ are derived from VH1 germline gene [J]. Blood,2000,95(2):558-563.
6[7]Verbruggen B, Giles A, Samis J, et al. The type of factor Ⅷ deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor Ⅷ inhibitors[J]. Thromb Haemost,2001,86(6):1435-1439.
7[8]Dazzi F, Tison T, Vianello F, et al. High incidence of anti-F Ⅷ antibodies against non-coagulant epitopes in haemophilia A patients: a possible role for the half-life of transfused FⅧ[J] . Br J Haematol, 1996,93(3):688-693.
8[9]Klinge J, Auerswald G, Budde U, et al. Detection of all anti-factor Ⅷ antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immnoprecipitation assay[J]. Haemophilia,2001,7(1):26-32.
9[10]Lindgren A,Wadenvik H,TengbornL, et al. Characterization of inhibitors to F Ⅷ with an ELISA in congenital and acquired haemophilia A [J]. Haemophilia,2002,8 (5):644-648.
